Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

Background As coronavirus disease 2019 (COVID-19) pandemic rages on, there is urgent
need for identification of clinical and laboratory predictors for progression towards severe …

Abstract Background Coronavirus disease 2019 (COVID-19) emerged first in December
2019 in Wuhan, China and quickly spread throughout the world. Clinical and laboratory data …

Context.—A relevant portion of coronavirus disease 2019 (COVID-19) patients develop
severe disease with negative outcomes. Several biomarkers have been proposed to predict …

Background Laboratory testing is commonly performed in patients with COVID-19. Each of
the laboratory parameters has potential value for risk stratification and prediction of COVID …

Aims As of the 28th April 2020, the COVID-19 pandemic has infiltrated over 200 countries
and affected over three million confirmed people. We review different biomarkers to evaluate …

During a severe infection such as coronavirus disease 2019 (COVID-19), the level of almost
all analytes can change, presenting a correlation with disease severity and survival; …

Objective Evidence-based characterization of the diagnostic and prognostic value of the
hematological and immunological markers related to the epidemic of Coronavirus Disease …

Background Patients with severe coronavirus disease 2019 (COVID-19) develop acute
respiratory distress and multi-system organ failure and are associated with poor prognosis …

Background The severity and outcome of COVID-19 cases has been associated with the
percentage of circulating lymphocytes (LYM%), levels of C-reactive protein (CRP) …